Skip to main content

Table 1 AD-risk loci identified through genome-wide analyses (GWAS and GWAX) [24, 25]

From: Late onset Alzheimer’s disease genetics implicates microglial pathways in disease risk

SNP

Chr

Reported gene

Additional genes in locus

rs6656401

1

CR1

 

rs6733839

2

BIN1

 

rs35349669

2

INPP5D

NGEF, NEU2

rs190982

5

MEF2C

LOC645323, MIR9-2

rs2074612a

5

SCIMP

ZNF594, RABEP1, USP6

rs9271192

6

HLA-DRB5–

HLA-DRB1

C6orf10, HLA-DRB5, HLA-DRB6, HLA-DRB1, HLA-DQA1, HCG23, BTNL2, HLA-DRA, HLA-DQB1, HLA-DQA2, HLA-DQB2, HLA-DOB, TAP1, TAP2, PSMB8, PSMB9

rs10948363

6

CD2AP

GPR111, GPR115

rs2718058

7

NME8

GPR141

rs1476679

7

ZCWPW1

TRIM4, GJC3, AZGP1, AZGP1P1, ZKSCAN1, ZSCAN21, ZNF3, COPS6, MCM7, C7orf59, GPC2, STAG3, GATS, PVRIG, SPDYE3, PMS2P1, PILRA, PILRB, PPP1R35, MEPCE, NYAP1, SAP25, AGFG2, LRCH4, ZASP, LRCH4, FBXO24, PCOLCE-AS1

rs11771145

7

EPHA1

CLCN1, FAM131B, ZYX, TAS2R60, LOC285965, TAS2R41

rs28834970

8

PTK2B

STMN4, TRIM35, CHRNA2, EPHX2

rs9331896

8

CLU

PTK2B, CHRNA2, EPHX2, SCARA3, CCDC25, ESCO2, PBK

rs7920721a

10

ECHDC3

 

rs10838725

11

CELF1

ARFGAP2, PACSIN3, DDB2, ACP2, MADD, MYBPC3, SPI1, SLC39A13, PSMC3, RAPSN, PTPMT1, KBTBD4, NDUFS3, C1QTNF4, MTCH2, AGBL2, FNBP4, NUP160

rs983392

11

MS4A6A

PLAC1L, MS4A3, MS4A2, MS4A4A, MS4A6E

rs10792832

11

PICALM

CCDC83

rs11218343

11

SORL1

 

rs17125944

14

FERMT2

ERO1L, PSMC6, STYX, GNPNAT1

rs10498633

14

SLC24A4

RIN3

rs59685680a

15

SPPL2A

TRPM7, USP50

rs77493189a

17

HBEGF

HBEGF

rs4147929

19

ABCA7

CFD, MED16, PRTN3, R3HDM4, KISS1R, ELANE, ARID3A, TMEM259, GRIN3B, WDR18, HMHA1, CNN2, POLR2E, SBNO2, GPX4, ATP5D, MIDN, CIRBP, EFNA2

rs7274581

20

CASS4

CSTF1, RTFDC1, GCNT7, FAM209A, FAM209B

  1. Disease-associated SNPs that have reached genome-wide significance for each locus are labeled, along with their chromosome, the closest gene (that which is reported) and additional genes within the locus
  2. aidentified in GWAX